Lactoferricin B Combined with Antibiotics Exhibits Leukemic Selectivity and Antimicrobial Activity
Jan Jakub Lica,Katarzyna Gucwa,Mateusz Heldt,Anna Stupak,Natalia Maciejewska,Natalia Ptaszyńska,Anna Łęgowska,Bhaskar Pradhan,Agata Gitlin-Domagalska,Dawid Dębowski,Joanna Jakóbkiewicz-Banecka,Krzysztof Rolka
DOI: https://doi.org/10.3390/molecules29030678
IF: 4.6
2024-02-01
Molecules
Abstract:The fusion of penetrating peptides (PPs), e.g., cell penetration peptides (CPPs) or antimicrobial peptides (AMPs), together with antimicrobial agents is an expanding research field. Specific AMPs, such as lactoferricin B (LfcinB), have demonstrated strong antibacterial, antifungal, and antiparasitic activity, as well as valuable anticancer activity, proving beneficial in the development of anticancer conjugates. The resulting conjugates offer potential dual functionality, acting as both an anticancer and an antimicrobial agent. This is especially necessary in cancer treatment, where microbial infections pose a critical risk. Leukemic cells frequently exhibit altered outer lipid membranes compared to healthy cells, making them more sensitive to compounds that interfere with their membrane. In this study, we revisited and reanalyzed our earlier research on LfcinB and its conjugates. Furthermore, we carried out new experiments with a specific focus on cell proliferation, changes in membrane asymmetric phosphatidylserine location, intracellular reactive oxygen species (ROS) generation, mitochondrial functions, and in vitro bacterial topoisomerase inhibition.
chemistry, multidisciplinary,biochemistry & molecular biology